Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events

被引:34
作者
Wlodarska, Iwona [1 ]
Matthews, Christine
Veyt, Ellen
Pospisilova, Helena
Catherwood, Mark A.
Poulsen, Tim S.
Vanhentenrijk, Vera
Ibbotson, Rachel
Vandenberghe, Peter
Morris, T. C. M. 'Curly'
Alexander, H. Denis
机构
[1] Catholic Univ Louvain, Dept Human Genet, Herestr 49, B-3000 Louvain, Belgium
[2] Catholic Univ Louvain, Dept Pathol, B-3000 Louvain, Belgium
[3] Belfast City Hosp, Dept Haematol, Belfast BT9 7AD, Antrim, North Ireland
[4] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland
[5] DakoCytomat Denmark AS, Glostrup, Denmark
[6] Royal Bournemouth Hosp, Dept Pathol, Bournemouth, Dorset, England
关键词
D O I
10.2353/jmoldx.2007.060088
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Routine interphase fluorescence in situ hybridization (FISH) analysis of chronic lymphocytic leukemia (CLL) with LSI IGH/CCND1 assay, applied to differentiate CLL from leukemic mantle cell lymphoma, identified a subset of cases (42/174) with translocation-like IGH signal pattern. To unravel the underlying 14q32/IGH aberrations, 14 of these cases were subjected to cytogenetic, detailed FISH, and V-H mutation analyses. FISH identified cryptic losses of various portions of the IGHV region in all 14 cases. Fine mapping of these V-H deletions revealed a strict correlation between their distal border and localization of the used V-H gene suggesting that they are not oncogenic but reflect physiological events accompanying somatic V-D-J assembly. This hypothesis was further supported by FISH analysis of 20 CLL and hairy cell leukemia cases with the known V-H usage showing a constant loss of sequences proximal to the used gene, identification of V-H deletions in normal B cells, and their exclusive demonstration in B cell malignancies, but not of T cell and myeloid linage. Given that these cryptic physiological V-H losses in B cells may seriously complicate analysis of B cell leukemia/lymphoma and lead to false conclusions, FISH users should take them into consideration when interpreting IGH aberrations in these malignancies.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 24 条
[1]  
Alexander HD, 2001, LEUK LYMPHOMA S1, V42, P41
[2]  
[Anonymous], 1996, Nat Genet, V14, P86
[3]   The mechanism and regulation of chromosomal V(D)J recombination [J].
Bassing, CH ;
Swat, W ;
Alt, FW .
CELL, 2002, 109 :S45-S55
[4]   Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes [J].
de Leeuw, RJ ;
Davies, JJ ;
Rosenwald, A ;
Bebb, G ;
Gascoyne, RD ;
Dyer, MJS ;
Staudt, LM ;
Martinez-Climent, JA ;
Lam, WL .
HUMAN MOLECULAR GENETICS, 2004, 13 (17) :1827-1837
[5]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[6]  
Dyer MJS, 2002, LEUKEMIA, V16, P973, DOI 10.1038/sj.leu.2402528
[7]   Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia [J].
Fink, SR ;
Paternoster, SE ;
Smoley, SA ;
Flynn, HC ;
Geyer, SM ;
Shanafelt, TD ;
Lee, YK ;
Jelinek, DE ;
Kay, NE ;
Dewald, GW .
LEUKEMIA RESEARCH, 2005, 29 (03) :253-262
[8]   Translocation t(14;18) and gain of chromosome 18/BCL2:: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas [J].
Galteland, E ;
Sivertsen, EA ;
Svendsrud, DH ;
Smedshammer, L ;
Kresse, SH ;
Meza-Zepeda, LA ;
Myklebost, O ;
Suo, Z ;
Mu, D ;
DeAngelis, PM ;
Stokke, T .
LEUKEMIA, 2005, 19 (12) :2313-2323
[9]  
ISCN, 1995, INT SYST HUM CYT NOM
[10]   Mechanisms of chromosomal translocations in B cell lymphomas [J].
Küppers, R ;
Dalla-Favera, R .
ONCOGENE, 2001, 20 (40) :5580-5594